Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 86 citing articles:

Gut barrier disruption and chronic disease
Jan Martel, Shih-Hsin Chang, Yun‐Fei Ko, et al.
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 4, pp. 247-265
Closed Access | Times Cited: 296
Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice
Shuo Li, Jinming You, Zirui Wang, et al.
Food Research International (2021) Vol. 143, pp. 110270-110270
Closed Access | Times Cited: 132
The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease
Mohamad Hizami Mohamad Nor, Nurainina Ayob, Norfilza Mohd Mokhtar, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3192-3192
Open Access | Times Cited: 116
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 180-200
Open Access | Times Cited: 44
Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice
Dan Feng, Hongmin Zhang, Xin Jiang, et al.
Environmental Pollution (2020) Vol. 265, pp. 114880-114880
Closed Access | Times Cited: 114
Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives
Karen Salve Coutinho‐Wolino, Patrícia Pereira Almeida, Denise Mafra, et al.
Nutrition Research (2022) Vol. 107, pp. 96-116
Open Access | Times Cited: 51
Mesona chinensis Benth Polysaccharides Alleviate DSS‐Induced Ulcerative Colitis via Inhibiting of TLR4/MAPK/NF‐κB Signaling Pathways and Modulating Intestinal Microbiota
Hanyu Lu, Mingyue Shen, Ting Chen, et al.
Molecular Nutrition & Food Research (2022) Vol. 66, Iss. 15
Closed Access | Times Cited: 41
Potential Role of Curcumin for the Treatment of Major Depressive Disorder
Adrian L. Lopresti
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 123-141
Open Access | Times Cited: 39
Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress
Pin Gong, Hui Long, Yuxi Guo, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116927-116927
Closed Access | Times Cited: 32
Bioactives and their roles in bone metabolism of osteoarthritis: evidence and mechanisms on gut-bone axis
Sanjay Basak, Kota Sri Naga Hridayanka, Asim K. Duttaroy
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9
Single and combined effects of high-fat diet and ammonia nitrogen on oxidative stress, lipid accumulation and inflammation in liver of grass carp Ctenopharyngodon idella
Cheng Zhang, Wenhao Huang, Xiaotian Zhang, et al.
Aquaculture (2024) Vol. 589, pp. 740973-740973
Closed Access | Times Cited: 8
Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high‐fat diet
Ting Yu, Yan Wang, Xiaosu Chen, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 15, pp. 8603-8613
Open Access | Times Cited: 59
Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
Honglin Zhou, Cheng Ma, Cheng Wang, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173976-173976
Closed Access | Times Cited: 51
Curcumin mitigates deoxynivalenol-induced intestinal epithelial barrier disruption by regulating Nrf2/p53 and NF-κB/MLCK signaling in mice
Zheng Cao, Jinsong Gao, Wanyue Huang, et al.
Food and Chemical Toxicology (2022) Vol. 167, pp. 113281-113281
Closed Access | Times Cited: 34
Effects of exercise on high-fat diet–induced non-alcoholic fatty liver disease and lipid metabolism in ApoE knockout mice
Wen-Ching Huang, Jinwei Xu, Shiming Li, et al.
Nutrition & Metabolism (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with non-alcoholic simple fatty liver disease: a randomized controlled trial
Youming He, Xiaobing Chen, Yongchun Li, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 1, pp. 66-79
Closed Access | Times Cited: 7
Curcumin attenuates aflatoxin B1-induced ileum injury in ducks by inhibiting NLRP3 inflammasome and regulating TLR4/NF-κB signaling pathway
Hang Pan, Ting Hu, Ying He, et al.
Mycotoxin Research (2024) Vol. 40, Iss. 2, pp. 255-268
Closed Access | Times Cited: 6
Curcumin improves insulin sensitivity and increases energy expenditure in high-fat-diet–induced obese mice associated with activation of FNDC5/irisin
Tiande Zou, Shuo Li, Bo Wang, et al.
Nutrition (2021) Vol. 90, pp. 111263-111263
Closed Access | Times Cited: 33
Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms
Hager H. Shaaban, Ibrahim AlZaim, Ahmed El‐Mallah, et al.
Life Sciences (2022) Vol. 308, pp. 120956-120956
Closed Access | Times Cited: 27
Curcumin Alleviates High-fat Diet-induced Nonalcoholic Steatohepatitis via Improving Hepatic Endothelial Function with Microbial Biotransformation in Rats
Jiazhen Wu, Mengyao Li, Ning Huang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 27, pp. 10338-10348
Closed Access | Times Cited: 16
The improvement of intestinal dysbiosis and hepatic metabolic dysfunction in dextran sulfate sodium‐induced colitis mice: effects of curcumin
Feini Zhou, Ting Mai, Ziren Wang, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 8, pp. 1333-1345
Closed Access | Times Cited: 15
Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease
Marta Guariglia, Francesca Saba, Chiara Rosso, et al.
Nutrients (2023) Vol. 15, Iss. 24, pp. 5053-5053
Open Access | Times Cited: 15
Polysaccharides from Ostrea rivularis rebuild the balance of gut microbiota to ameliorate non-alcoholic fatty liver disease in ApoE−/− mice
Lijun Zhu, Mingmei Xiao, Jigang Luo, et al.
International Journal of Biological Macromolecules (2023) Vol. 235, pp. 123853-123853
Closed Access | Times Cited: 14
Protective role of curcumin in disease progression from non-alcoholic fatty liver disease to hepatocellular carcinoma: a meta-analysis
Yubing Li, Xinyu Deng, Xiyue Tan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway
Yingli Liu, Qiu-Zan Zhang, Yanrong Wang, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top